Trial Profile
Evaluation of Oxidative and Antioxidative Status of Pregnant Women Suffering From Threatened Preterm Birth During Tocolytic Treatment With Atosiban
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Atosiban (Primary)
- Indications Preterm labour
- Focus Therapeutic Use
- 13 Jun 2019 Status changed from active, no longer recruiting to completed.
- 03 Jul 2018 New trial record